Pricing

Iterum Therapeutics Plc (ITRM)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Corey N. Fishman
Employees:
10
FITZWILLIAM COURT, 1ST FLOOR, LEESON CLOSE, DUBLIN 2, L2, D02 YW24
(872) 225-6077
Stock Split History
DateRatio
2022-08-18 1:15
Iterum Therapeutics plc is developing sulopenem, a novel anti-infective compound with oral and IV formulations. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available